A German Federal Court decision has given patent applicants in the life sciences field plenty to think about, as Wolfgang Bublak and Axel Berger explain.
Last year, the German Federal Court of Justice (FCJ) rendered its much noted decision in the UV-unempfindliche Druckplatte (UV-insensitive printing plate; docket number X ZR 3/10) case, that highlights the requirements for claiming priority.
According to German practice, two requirements have to be fulfilled in order to claim priority from an earlier application by filing “the same invention” as stipulated, eg, in Article 40(1) of the German Patent Act or in Article 87(1) of the European Patent Convention (EPC): (i) the invention including all of its features needs to be disclosed “directly and unambiguously” in the earlier application; and (ii) all features need to be disclosed “as belonging to the invention”, ie, as possible embodiments of the invention.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
Priority, disclosure, German Federal Court, UV-unempfindliche Druckplatte, novelty